Tanvex Biopharma Stock Working Capital
6541 Stock | TWD 70.30 2.20 3.23% |
Tanvex BioPharma fundamentals help investors to digest information that contributes to Tanvex BioPharma's financial success or failures. It also enables traders to predict the movement of Tanvex Stock. The fundamental analysis module provides a way to measure Tanvex BioPharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tanvex BioPharma stock.
Tanvex |
Tanvex BioPharma Company Working Capital Analysis
Tanvex BioPharma's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
In accordance with the company's disclosures, Tanvex BioPharma has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The working capital for all Taiwan stocks is 100.0% higher than that of the company.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Tanvex Fundamentals
Return On Equity | -0.6 | |||
Return On Asset | -0.2 | |||
Operating Margin | (76.42) % | |||
Current Valuation | 14.19 B | |||
Shares Outstanding | 352.74 M | |||
Shares Owned By Insiders | 53.74 % | |||
Shares Owned By Institutions | 4.30 % | |||
Price To Book | 7.12 X | |||
Price To Sales | 681.78 X | |||
Revenue | 5.41 M | |||
Gross Profit | 3.55 M | |||
EBITDA | (1.25 B) | |||
Net Income | (1.54 B) | |||
Cash And Equivalents | 1.65 B | |||
Cash Per Share | 5.29 X | |||
Debt To Equity | 0.67 % | |||
Current Ratio | 7.89 X | |||
Book Value Per Share | 5.35 X | |||
Cash Flow From Operations | (1.39 B) | |||
Earnings Per Share | (4.35) X | |||
Target Price | 52.4 | |||
Number Of Employees | 23 | |||
Beta | 0.67 | |||
Market Capitalization | 17.11 B | |||
Total Asset | 4.71 B | |||
Net Asset | 4.71 B |
About Tanvex BioPharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tanvex BioPharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanvex BioPharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanvex BioPharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tanvex Stock Analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.